Trial intelligence / Profile preview

Open randomized comparison of TachoSil in breast surgery patients at risk of bleeding

2009-016814-25Phase 4Active

Sponsor
Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
Start
Dec 2009
Modality
Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tachosil in breast cancer (2 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Started Dec 2009; status: active.

02

Drugs

tachosil
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2009-016814-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016814-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call